It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
Molecular glues are enjoying the spotlight, but discovering new ones is often a matter of luck. A new method, developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results